January 2024
1. MORALES-CASADO MI, Diezma-Martin AM, Munoz-Escudero F, Ronsenstone-Calvo S, et al
   Association between myasthenia gravis and Alzheimer's disease.
   Rev Neurol. 2024;78:41-46.
   

   >> Share

   
   March 2023
2. PEREZ-MARTINEZ DA
   [Lecanemab in Alzheimer's disease: are we really before a shift in the prognosis of the disease?].
   Rev Neurol. 2023;76:185-188.
   

   >> Share

   
   October 2022
3. POUDEVIDA S, de Sola S, Brugulat-Serrat A, Mas-Vall Llosera G, et al
   [Effectiveness of a psychotherapeutic intervention group program in the improvement of caregiver well-being in Alzheimer's disease patients' family caregivers: the CuiDem study].
   Rev Neurol. 2022;75:203-211.
   

   >> Share

   
   April 2022
4. LABOS E, Guajardo ME, Soderlund ME, Pagotto V, et al
   [Vascular damage and cognitive-functional performance in a population with mild cognitive impairment].
   Rev Neurol. 2022;74:209-218.
   

   >> Share

   
   March 2022
5. DAL-RE R
   [The European Medicines Agency rejects the authorization of aducanumab for Alzheimer's disease].
   Rev Neurol. 2022;74:207-208.
   

   >> Share

   
   October 2021
6. DAL-RE R
   [Aducanumab approval for Alzheimer's disease in the USA: the surrender of science].
   Rev Neurol. 2021;73:296-297.
   

   >> Share

   
   June 2021
7. MONGE-GARCIA V, Llorca-Tolon L, Gasparini-Berenguer R, Monge-Argiles JA, et al
   [Role of the Ass1-42/Ass1-40 ratio in the concept 'Alzheimer's disease contributes to mild cognitive impairment'].
   Rev Neurol. 2021;72:371-376.
   

   >> Share

   
   November 2020
8. DEVI-BASTIDA J, Catala-Sune N, Jofre-Font S
   [Bilingualism as a factor in the protection of Alzheimer's disease: a systematic review].
   Rev Neurol. 2020;71:353-364.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share